AstraZeneca: Fasenra approved for self-injection
(CercleFinance.com) - AstraZeneca announced on Friday that the US Food and Drug Administration (FDA) has approved Fasenra's principle of self-administration in a pre-filled, single-use auto-injector.
This approval is supported by data from the GRECO Phase III trial and the AMES Phase I trial. The safety and tolerability of Fasenra in these trials were consistent with the established drug profile.
The self-administration of Fasenra and the Fasenra pen are also approved in the European Union.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
This approval is supported by data from the GRECO Phase III trial and the AMES Phase I trial. The safety and tolerability of Fasenra in these trials were consistent with the established drug profile.
The self-administration of Fasenra and the Fasenra pen are also approved in the European Union.
Copyright (c) 2019 CercleFinance.com. All rights reserved.